Study results demonstrate that statins have antitumor activity in various solid-tumor cancers and leukemia; however, experts offer these caveats on using them to treat cancer — at least for now.
Statins provide no benefits, or adverse effects, in patients with lung cancer, according to a phase 3 trial.
Statins could be an effective agent for the treatment of patients with metastatic small cell lung cancer.
New guidelines released by the American College of Cardiology (ACC) and the American Heart Association (AHA) would have 13 million more Americans taking the cholesterol drugs, experts say.
Statin use may slow prostate cancer progression in patients receiving androgen deprivation therapy, but more trials are needed to confirm benefits, researchers say.
The use of statins for a year before a diagnosis of lung cancer is associated with a lower risk of cancer-specific mortality, but more research is needed.
Risk reduction appears sex specific, with significant reduction seen for men, but not women.
Findings among men taking a statin alongside androgen deprivation therapy showed additional months of progression-free survival.
Low density lipoprotein (LDL), or "bad cholesterol," stays the same or increases after taking statin medications.
Clinical trials on the use of statins as an anticancer drug have yielded mixed results.
Use of statins is associated with a reduced risk of progression of localized renal cell carcinoma, according to research.
Sign Up for Free e-newsletters
- Is Radioimmunotherapy a Path Forward for Melanoma?
- FDA Approves Mogamulizumab-kpkc for Rare Subtypes of Non-Hodgkin Lymphoma
- New PDL1 Inhibitors for Non-small Cell Lung Cancer: Focus on Pembrolizumab
- Intensive Chemotherapy May Not Be Effective in MDS or AML After MDS
- ASCO Endorses SIO Guideline for Integrative Therapies in Breast Cancer
- Seeking Reliable Information on Herbal Products
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Adhering to Cytoreductive Therapy Use May Improve Outcomes in Polycythemia Vera
- Disparities Remain in Prevalence of Cancer Screening Tests
- Hope, Gratitude, and Spirituality: What They Mean to Cancer Patients
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- 8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|